COVID 19 News and Research

RSS

Supercomputer simulations reveal the behavior of dominant G form SARS-CoV-2 strain

Large-scale supercomputer simulations at the atomic level show that the dominant G form variant of the COVID-19-causing virus is more infectious partly because of its greater ability to readily bind to its target host receptor in the body, compared to other variants.

19 Apr 2021

Air pollution may increase chance of hospitalization for COVID-19 patients

Patients who have preexisting respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD) and live in areas with high levels of air pollution have a greater chance of hospitalization if they contract COVID-19, says a University of Cincinnati researcher.

15 Apr 2021

New simpler, faster system for analyzing mutations in SARS-CoV-2

Although it is known that mutations in the SARS-CoV-2 genome occurred and spread, the effect of those mutations is not yet clear.

From Osaka University 14 Apr 2021

Scanning & Decoding Tube Racks Direct from Low Temperature Storage

Ziath has posted a new video that provides an easy-to-follow guide to assist scientists and technicians scanning and decoding sample tube racks direct from low-temperature storage.

From Ziath Ltd 9 Apr 2021

Logical next steps to implement a community vision for the future of biodiversity collections

Events such as the COVID-19 pandemic have highlighted the crucial role played by biodiversity collections in enabling rapid responses to crises and in facilitating ongoing research across numerous fields. Despite the recognized value of this infrastructure, the community nevertheless has further opportunities to maximize its value to the scientific enterprise.

8 Apr 2021

Researchers take a key step toward new drugs and vaccines for combating COVID-19

Scientists have achieved a huge step toward new vaccines and drugs for fighting against COVID-19.

6 Apr 2021

Low K777 concentrations inhibit cathepsin L and reduce SARS-CoV-2’s ability to infect host cell lines

For a long time, James McKerrow, MD, PhD, dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, has investigated neglected tropical diseases, which are chronic, disabling parasitic infections mainly affecting the poor and underserved communities in developing nations.

From UC San Diego 5 Apr 2021

New AI-based method can lead to faster, low-cost development of protein-based drugs

Thanks to a newly published study by scientists, artificial intelligence (AI) can now create novel and functionally active proteins.

1 Apr 2021

Targeting epigenetic mechanisms to advance pharmacological treatments for alcoholism

Abusive alcohol drinking considerably impacts human health. Alcoholism, better defined as Alcohol Use Disorders (AUD), includes a group of pathological entities related to alcohol-induced damage.

1 Apr 2021

B.1.1.7 variant of SARS-CoV-2 spreading quickly in the United States

The faster-spreading B.1.1.7 variant of SARS-CoV-2 first detected in the United Kingdom, the coronavirus that causes COVID-19, is quickly on its way to becoming the dominant variant of the virus in the United States, according to a study from scientists at Scripps Research and the COVID-19 test maker Helix.

31 Mar 2021

Virus-cell interaction may explain the high infection rate of COVID-19 virus

Bioengineering scientists have now detected a formerly unknown interaction between the spike (or “S”) protein of SARS-CoV-2 and receptors in human cells.

From Lehigh University 29 Mar 2021

Study shows how WAVE2 protein maintains the immune system balance

Sinai Health researchers have reported that they have uncovered a new mechanism that regulates harmful overreactions in the body’s immune system.

26 Mar 2021

New technique can measure thousands of proteins in a few minutes

Researchers from Charité - Universitätsmedizin Berlin and the Francis Crick Institute have developed a mass spectrometry-based technique capable of measuring samples containing thousands of proteins within just a few minutes.

26 Mar 2021

Salivary gland cells could play role in SARS-CoV-2 virus transmission

Scientists have shown that SARS-CoV-2, the virus that causes COVID-19, can infect specific cells in the salivary gland in the mouth.

26 Mar 2021

Antibody used for COVID-19 therapy can no longer inhibit new SARS-CoV-2 variants

Cell culture studies show that mutated viruses are less susceptible to inhibition by antibodies from recovered or vaccinated individuals.

26 Mar 2021

New label-free immune profiling assay to assess rapidly changing host immune response

Researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP), an Interdisciplinary Research Group (IRG) at the Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, have developed a new label-free immune profiling assay that profiles the rapidly changing host immune response in case of infection, in a departure from existing methods that focus on detecting the pathogens themselves, which can often be at low levels within a host.

26 Mar 2021

Silencing a key protein to “domesticate” COVID-19 virus

When cells in the human body are invaded by a virus, they send a signal to adjacent cells to boost their antiviral defenses to stop the spread of infection.

25 Mar 2021

Scientists generate a detailed molecular atlas of lung development

Researchers at the Perelman School of Medicine at the University of Pennsylvania have produced a detailed molecular atlas of lung development, which is expected to be a fundamental reference in future studies of mammalian biology and of new treatments for diseases, such as COVID-19, that affect the lungs.

25 Mar 2021

Study shows SARS-CoV-2 antibodies wane at different rates

Researchers from Duke-NUS Medical School, the National Centre for Infectious Diseases (NCID), and the Agency for Science, Technology and Research (A*STAR) Infectious Diseases Labs have discovered that antibodies against SARS-CoV-2 decline at different speeds, and these antibodies last for only a few days in some people but remain for many years in other individuals.

24 Mar 2021

Hormone drugs may help disarm coronavirus spike protein and stop disease progression

Hormone drugs that reduce androgen levels may help disarm the coronavirus spike protein used to infect cells and stop the progression of severe COVID-19 disease, suggests a new preclinical study from researchers in the Abramson Cancer Center at the University of Pennsylvania and published online in Cell Press's iScience.

23 Mar 2021

COVID 19 News and Research

Supercomputer simulations reveal the behavior of dominant G form SARS-CoV-2 strain

Air pollution may increase chance of hospitalization for COVID-19 patients

New simpler, faster system for analyzing mutations in SARS-CoV-2

Scanning & Decoding Tube Racks Direct from Low Temperature Storage

Logical next steps to implement a community vision for the future of biodiversity collections

Researchers take a key step toward new drugs and vaccines for combating COVID-19

Low K777 concentrations inhibit cathepsin L and reduce SARS-CoV-2’s ability to infect host cell lines

New AI-based method can lead to faster, low-cost development of protein-based drugs

Targeting epigenetic mechanisms to advance pharmacological treatments for alcoholism

B.1.1.7 variant of SARS-CoV-2 spreading quickly in the United States

Virus-cell interaction may explain the high infection rate of COVID-19 virus

Study shows how WAVE2 protein maintains the immune system balance

New technique can measure thousands of proteins in a few minutes

Salivary gland cells could play role in SARS-CoV-2 virus transmission

Antibody used for COVID-19 therapy can no longer inhibit new SARS-CoV-2 variants

New label-free immune profiling assay to assess rapidly changing host immune response

Silencing a key protein to “domesticate” COVID-19 virus

Scientists generate a detailed molecular atlas of lung development

Study shows SARS-CoV-2 antibodies wane at different rates

Hormone drugs may help disarm coronavirus spike protein and stop disease progression

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics